Normoalbuminuric chronic kidney disease in diabetes


Cite item

Full Text

Abstract

Urinary albumin excretion (UAE) is widely used in clinical practice as indicator of diabetic kidney disease. According to the classical concept of the natural course of diabetic nephropathy, an increase in UAE usually precedes a decline in renal function. Meanwhile, a growing body of evidences indicates a high prevalence of normoalbuminuric chronic kidney disease (NA-CKD) in diabetic subjects, especially among patients with type 2 diabetes. An increase in NA-CKD prevalence can be results of improved glucose, blood pressure, and lipid control, widespread use of renin-angiotensin system blockers, and smoking cessation. It was shown that NA-CKD is more prevalent among women and is associated with arterial hypertension and coronary artery disease. The renal structure in subjects with NA-CKD is more heterogeneous when compared to patients with increased albuminuria, wherein interstitial changes and arteriolosclerosis could be the principal morphological findings, while signs of glomerulopathy may be absent. The prognostic value of NA-CKD needs to be clarified. It was shown that NA-CKD increases the risk of myocardial infarction, stroke and cardiovascular death in patients with diabetes. The search for alternative diagnostic markers for detecting of diabetic kidney disease in the absence of albuminuria, is of practical importance. The evaluations of the markers of tubular damage and interstitial fibrosis, as well as proteomic approaches, are considered as perspective diagnostic and prognostic options in NA-CKD. The study of pathogenesis, pathology, clinical course of NA-CKD in diabetic patients, as well as the development of more specific diagnostic and treatment options is a challenge for future research.

About the authors

V V Klimontov

Research Institute of Clinical and Experimental Lymphology - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

Email: klimontov@mail.ru
д.м.н., проф., зам. руководителя филиала по научной работе, зав. лаб. эндокринологии; тел.: +7(383)335-96-33; e-mail: klimontov@mail.ru; ORCID: 0000-0002-5407-8722 Novosibirsk, Russia

A I Korbut

Research Institute of Clinical and Experimental Lymphology - Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences

м.н.с. лаб. эндокринологии; ORCID: 0000-0003-3502-5892 Novosibirsk, Russia

References

  1. Шестакова М.В. Сахарный диабет и хроническая болезнь почек: современная диагностика и лечение. Вестник Российской академии медицинских наук. 2012;65(1):45-49.
  2. Marshall S.M. Natural history and clinical characteristics of CKD in type 1 and type 2 diabetes mellitus. Adv Chronic Kidney Dis. 2014;21(3):267-272. doi: 10.1053/j.ackd.2014.03.007
  3. Chen C, Wang C, Hu C, Han Y, Zhao L, Zhu X, Xiao L, Sun L. Normoalbuminuric diabetic kidney disease. Front Med. 2017; in press. doi: 10.1007/s11684-017-0542-7
  4. Porrini E, Ruggenenti P, Mogensen C.E, Barlovic D.P, Praga M, Cruzado J.M, Hojs R, Abbate M, de Vries AP; ERA-EDTA Diabesity Working Group. Non - proteinuric pathways in loss of renal function in patients with type 2 diabetes. Lancet Diabetes Endocrinol. 2015;3(5):382-391. doi: 10.1016/S2213-8587(15)00094-7
  5. Afkarian M, Zelnick L.R, Hall Y.N, et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014. JAMA. 2016;316(6):602-610. doi: 10.1001/jama.2016.10924
  6. Pavkov M.E, Mason C.C, Bennett P.H, Curtis J.M, Knowler W.C, Nelson R.G. Change in the distribution of albuminuria according to estimated glomerular filtration rate in Pima Indians with type 2 diabetes. Diabetes Care. 2009;32(10):1845-1850. doi: 10.2337/dc08-2325
  7. Penno G, Solini A, Bonora E, et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens. 2011;29(9):1802-1809. doi: 10.1097/HJH.0b013e3283495cd6
  8. Retnakaran R, Cull C.A, Thorne K.I, Adler A.I, Holman R.R; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes. 2006;55(6):1832-1839. doi: 10.2337/db05-1620
  9. Thomas M.C, Weekes A.J, Broadley O.J, Cooper M.E, Mathew T.H. The burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study). Med J Aust. 2006;185(3):140-144.
  10. Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, Mifune M, Togane M. High frequencies of diabetic micro - and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria. Nephrol Dial Transplant. 2010;25(4):1161-1167. doi: 10.1093/ndt/gfp579
  11. Molitch M.E, Steffes M, Sun W, et al. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2010;33(7):1536-1543. doi: 10.2337/dc09-1098
  12. Thorn L.M, Gordin D, Harjutsalo V, Hägg S, Masar R, Saraheimo M, Tolonen N, Wadén J, Groop P.H, Forsblom CM; FinnDiane Study Group. The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes. Diabetes Care. 2015;38(11):2128-2133. doi: 10.2337/dc15-0641
  13. Penno G, Russo E, Garofolo M, Daniele G, Lucchesi D, Giusti L, Sancho Bornez V, Bianchi C, Dardano A, Miccoli R, Del Prato S. Evidence for two distinct phenotypes of chronic kidney disease in individuals with type 1 diabetes mellitus. Diabetologia. 2017;60(6):1102-1113. doi: 10.1007/s00125-017-4251-1
  14. Pugliese G. Updating the natural history of diabetic nephropathy. Acta Diabetol. 2014;51(6):905-915. doi: 10.1007/s00592-014-0650-7
  15. Бондарь И.А., Климонтов В.В., Надеев А.П., Бгатова Н.П. Начальные изменения в почках у больных сахарным диабетом 1-го типа. Проблемы эндокринологии. 2007;53(5):3-8.
  16. Fioretto P, Caramori M.L, Mauer M. The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007. Diabetologia. 2008;51(8):1347-1355. doi: 10.1007/s00125-008-1051-7
  17. Caramori M.L, Fioretto P, Mauer M. Low glomerular filtration rate in normoalbuminuric type 1 diabetic patients: an indicator of more advanced glomerular lesions. Diabetes. 2003;52(4):1036-1040. doi: 10.2337/diabetes.52.4.1036
  18. Dalla Vestra M, Masiero A, Roiter A.M, Saller A, Crepaldi G, Fioretto P. Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes. 2003;52(4):1031-1035. doi: 10.2337/diabetes.52.4.1031
  19. Weil E.J, Lemley K.V, Mason C.C, Yee B, Jones L.I, Blouch K, Lovato T, Richardson M, Myers B.D, Nelson R.G. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int. 2012;82(9):1010-1017. doi: 10.1038/ki.2012.234
  20. Ekinci E.I, Jerums G, Skene A, Crammer P, Power D, Cheong K.Y, Panagiotopoulos S, Mc Neil K, Baker S.T, Fioretto P, Macisaac R.J. Renal structure in normoalbuminuric and albuminuric patients with type 2 diabetes and impaired renal function. Diabetes Care. 2013;36(11):3620-3626. doi: 10.2337/dc12-2572
  21. Andrésdóttir G, Jensen M.L, Carstensen B, et al. Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int. 2015;87(2):417-426. doi: 10.1038/ki.2014.206
  22. Корбут А.И., Климонтов В.В. Терапия, основанная на инкретинах: почечные эффекты. Сахарный диабет. 2016;19(1):53-63. doi: 10.14341/DM7727
  23. Корбут А.И., Климонтов В.В. Эмпаглифлозин: новая стратегия нефропротекции при сахарном диабете. Сахарный диабет. 2017;20(1):75-84. doi: 10.14341/DM8005
  24. Boronat M, García-Cantón C, Quevedo V, et al. Non - albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus. Ren Fail. 2014;36(2):166-170. doi: 10.3109/0886022X.2013.835266
  25. Afghahi H, Cederholm J, Eliasson B, Zethelius B, Gudbjörnsdottir S, Hadimeri H, Svensson M.K. Risk factors for the development of albuminuria and renal impairment in type 2 diabetes - the Swedish National Diabetes Register (NDR). Nephrol Dial Transplant. 2011;26(4):1236-1243. doi: 10.1093/ndt/gfq535
  26. Ninomiya T, Perkovic V, de Galan B.E, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen C.E, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J; ADVANCE Collaborative Group. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813-1821. doi: 10.1681/ASN.2008121270
  27. Svensson M.K, Cederholm J, Eliasson B, Zethelius B, Gudbjörnsdottir S; Swedish National Diabetes Register. Albuminuria and renal function as predictors of cardiovascular events and mortality in a general population of patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register. Diab Vasc Dis Res. 2013;10(6):520-529. doi: 10.1177/1479164113500798
  28. Lin C.H, Chang Y.C, Chuang L.M. Early detection of diabetic kidney disease: Present limitations and future perspectives. World J Diabetes. 2016;7(14):290-301. doi: 10.4239/wjd.v7.i14.290
  29. Rigalleau V, Blanco L, Alexandre L, Pupier E, Lasseur C, Barthe N, Combe C. Normoalbuminuric chronic kidney disease in type 1 diabetes: is it real and is it serious? Diabetologia. 2017; in press. doi: 10.1007/s00125-017-4378-0
  30. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150. http://www.kdigo.org/clinical_practice_guidelines/pdf/CKD/KDIGO_2012_CKD_GL.pdf
  31. Климонтов В.В., Еременко Н.В., Мякина Н.Е., Фазуллина О.Н. Цистатин С и коллаген IV типа в диагностике хронической болезни почек у больных сахарным диабетом 2 типа. Сахарный диабет. 2015;18(1):87-93. doi: 10.14341/DM2015187-93
  32. Lacquaniti A, Donato V, Pintaudi B, Di Vieste G, Chirico V, Buemi A, Di Benedetto A, Arena A, Buemi M. "Normoalbuminuric" diabetic nephropathy: tubular damage and NGAL. Acta Diabetol. 2013;50(6):935-942. doi: 10.1007/s00592-013-0485-7
  33. Papadopoulou-Marketou N, Chrousos G.P, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab Res Rev. 2017;33(2). doi: 10.1002/dmrr.2841
  34. Bouvet B.R, Paparella C.V, Arriaga S.M, Monje A.L, Amarilla A.M, Almará A.M. Evaluation of urinary N-acetyl - beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus. Arq Bras Endocrinol Metabol. 2014;58(8):798-801. doi: 10.1590/0004-2730000003010
  35. Бондарь И.А., Климонтов В.В., Парфентьева Е.М., Романов В.В., Надеев А.П. Экскреция с мочой фиброгенных и антифиброгенных факторов роста у больных сахарным диабетом 1-го типа: взаимосвязь с диабетической нефропатией. Терапевтический архив. 2012;84(6):36-40.
  36. Шамхалова М.Ш., Курумова К.О., Клефортова И.И., Ситкин И.И., Ильин А.В., Арбузова М.И., Гончаров Н.П., Кация Г.В., Александров А.А., Кухаренко С.С., Шестакова М.В., Дедов И.И. Факторы развития тубулоинтерстициального повреждения почек у больных сахарным диабетом. Сахарный диабет. 2010;13(3):134-141. doi: 10.14341/2072-0351-5502
  37. Коненков В.И., Климонтов В.В., Мякина Н.Е., Тян Н.В., Фазуллина О.Н., Романов В.В. Повышенная концентрация воспалительных цитокинов в сыворотке крови у больных сахарным диабетом 2-го типа с хронической болезнью почек. Терапевтический архив. 2015;87(6):45-49. doi: 10.17116/terarkh201587645-49
  38. Carrero J.J, Grams M.E, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, Qureshi A.R, Evans M, Barany P, Lindholm B, Ballew S.H, Levey A.S, Gansevoort R.T, Elinder C.G, Coresh J. Albuminuria changes are associated with subsequent risk of end - stage renal disease and mortality. Kidney Int. 2017;91(1):244-251. doi: 10.1016/j.kint.2016.09.037
  39. Mayer G, Heerspink H.J, Aschauer C, Heinzel A, Heinze G, Kainz A, Sunzenauer J, Perco P, de Zeeuw D, Rossing P, Pena M, Oberbauer R; SYSKID Consortium. Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes. Diabetes Care. 2017;40(3):391-397. doi: 10.2337/dc16-2202
  40. Zürbig P, Jerums G, Hovind P, Macisaac R.J, Mischak H, Nielsen S.E, Panagiotopoulos S, Persson F, Rossing P. Urinary proteomics for early diagnosis in diabetic nephropathy. Diabetes. 2012;61(12):3304-3313. doi: 10.2337/db12-0348
  41. Pontillo C, Jacobs L, Staessen J.A, Schanstra J.P, Rossing P, Heerspink H.J, Siwy J, Mullen W, Vlahou A, Mischak H, Vanholder R, Zürbig P, Jankowski J. A urinary proteome - based classifier for the early detection of decline in glomerular filtration. Nephrol Dial Transplant. 2016; in press. doi: 10.1093/ndt/gfw239
  42. Argyropoulos C, Wang K, Mc Clarty S, Huang D, Bernardo J, Ellis D, Orchard T, Galas D, Johnson J. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS One. 2013;8(1):e54662. doi: 10.1371/journal.pone.0054662
  43. Камышова Е.С., Бобкова И.Н., Кутырина И.М. Современные представления о роли микроРНК при диабетической нефропатии: потенциальные биомаркеры и мишени таргетной терапии. Сахарный диабет. 2017;20(1):42-50. doi: 10.14341/DM8237

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies